In terms of the molecular mechanisms of non-EoE EGIDs, the unique effect of dupilumab in the acquisition of tolerance to causative foods in this case indicates that non-EoE EGIDs may be affected by both IgE- and non-IgE-mediated mechanisms, suggesting a mixed type of allergy. This evidence concerns the gene IGHE and allergic disease.